Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Completed · Phase 2

Conditions studied: Primary Biliary Cirrhosis

In brief

The purpose of this study was to determine if OCA had an effect on cholesterol levels in the blood in participants with primary biliary cirrhosis (PBC).

Key facts

Study ID

NCT01865812

Run by

Intercept Pharmaceuticals

People needed

27

Starts

2013-12-03

Expected to finish

2016-09-12

Last updated by the study team

2022-08-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Scripps Clinic — La Jolla, California, United States
• University of California, Davis Medical Center — Sacramento, California, United States
• University of Miami — Miami, Florida, United States
• Indiana University Medical Center — Indianapolis, Indiana, United States
• Beth Israel Medical Center — New York, New York, United States
• McGuire DVAMC — Richmond, Virginia, United States
• Swedish Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.